Association Between Helicobacter Pylori Infections and the Severity of COVID-19 in Iraqi Patients
DOI:
https://doi.org/10.33687/zrr7j517Keywords:
Helicobacter pylori, COVID-19, pandemic, severity, comorbidities, sociodemographic status.Abstract
Background and objective: Millions of cases of the COVID-19 pandemic have caused a worldwide health crisis. Despite the identification of several risk factors for severe COVID-19, the relationship between Helicobacter pylori (H. pylori) infection and COVID-19 severity remains uncertain. To clarify this association, a study will be conducted to investigate the possible link between H. pylori infection and COVID-19 severity in patients from Iraq.
Methods: A total of 424 COVID-19 patients who were admitted to different hospitals in Iraq from January to July 2022 were included in this retrospective study. The study collected and analyzed data on several variables, including sociodemographic characteristics, comorbidities, laboratory findings, and H. pylori infection status.
Results: Of the patient population, 198 individuals (46.7%) identified as male and 226 (53.3%) as female, with an average age of 49.6 years (range: 18-73 years). The majority of patients possessed at least one comorbidity, with hypertension (47.6%), diabetes mellitus (34.2%), and obesity (23.6%) being the most common. Among the patients observed, 101 (23.8%) had an H. pylori infection. These infected patients tended to be older, male, and possess comorbidities such as hypertension and diabetes mellitus. In terms of laboratory findings, patients with H. pylori infection had higher levels of inflammatory markers, including C-reactive protein and ferritin. Furthermore, patients with H. pylori infection had a higher incidence of severe COVID-19, necessitating mechanical ventilation and ICU admission.
Conclusions: The results of the study indicate a potential correlation between H. pylori infection and the severity of COVID-19 among patients in Iraq.
Downloads
References
1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. 2022 [Internet]. Available from: https://covid19.who.int/
2. Guan W-J, Liang W-H, Zhao Y, Liang H-R, Chen Z-S, Li Y-M, et al. Comorbidity and its impact on 1,590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.
3. Zheng KI, Feng G, Liu WY, Targher G, Byrne CD, Zheng MH, et al. Extrapulmonary complications of COVID-19: a multisystem disease? J Med Virol. 2021;93(1):323-335.
4. Singh S, Khan A, Chowdhry M. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. J Clin Med Res. 2021;13(4):213-224.
5. Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000;22(2):283-297.
6. Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420-429.
7. Yousif MG, Sadeq AM, Alfadhel SM, Al-Amran FG, Al-Jumeily D. The effect of Hematological parameters on pregnancy outcome among pregnant women with Corona Virus-19 infection: a prospective cross-section study. J Surv Fish Sci. 2023;10(3S):1425-1435.
8. Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: a review. World J Gastroenterol. 2015;21(23):6961-6971.
9. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis. 2008;198(4):553-560.
10. Hu Y, Feng Y, Wu J, Liu X, Zhao S. Relationship between Helicobacter pylori infection and chronic obstructive pulmonary disease: a meta-analysis. COPD. 2019;16(1):74-82.
11. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-e25.
12. CDC. People with Certain Medical Conditions [Internet]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. Accessed March 31, 2023.
13. Nakamura RM, Pinto E, Pinto MC, Appel-da-Silva MC, Carvalho SD. Prevalence of Helicobacter pylori infection in sex- and age-specific groups in a Brazilian urban population. Rev Inst Med Trop Sao Paulo. 2005;47(1):33-35.
14. Kalali B, Formichella L, Gerhard M. Diagnosis of Helicobacter pylori: Changes towards the Future. Diseases. 2014;2(3):203-213.
15. Shiota S, Suzuki R, Yamaoka Y. The significance of virulence factors in Helicobacter pylori. J Dig Dis. 2013;14(7):341-349.
16. Venerito M, Vasapolli R, Rokkas T, Delchier JC, Malfertheiner P. Helicobacter pylori, gastric cancer and other gastrointestinal malignancies. Helicobacter. 2021;22(S1):e12396.
17. Maggio R, Viscomi G. Helicobacter pylori infection and respiratory diseases: a review. J Clin Med Res. 2021;11(1):1-6.
18. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;323(8390):1311-1315.
19. Conteduca V, Sansonno D, Lauletta G, Russi S, Ingravallo G. H. pylori infection and gastric cancer: State of the art (review). Int J Oncol. 2013;42(1):5-18.
20. Nijevitch AA, Loguinovskaya VV. Helicobacter pylori in pathogenesis of diseases of respiratory organs. J Clin Microbiol. 2002;40(8):2845-2849.
21. Zhang L, Blot WJ. Helicobacter pylori and Gastric Cancer: A Confluence of Evidence. Cancer Epidemiol Biomarkers Prev. 2015;24(12):1786-1788.
22. Zhang Y, Du T, Chen X, Yu X. Association between Helicobacter pylori infection and asthma: a meta-analysis. Eur J Gastroenterol Hepatol. 2019;31(9):1087-1095.
23. Simon TG, Duberg AS, Aleman S, Chung RT, Chan AT, Ludvigsson JF. Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality. N Engl J Med. 2020;382(11):1018-1028.
Published
Data Availability Statement
microbiologist
Issue
Section
Categories
License
Copyright (c) 2025 Ahmed S. Salman, Maitham G. Yousif
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
